Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Other financing activities: 2015-2018

Historic Other financing activities for Intellia Therapeutics (NTLA) over the last 3 years, with Dec 2018 value amounting to $424,000.

  • Intellia Therapeutics' Other financing activities was N/A to $1.7 million in Q3 2016 from the same period last year, while for Sep 2016 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $424,000 for FY2018, which is N/A change from last year.
  • Intellia Therapeutics' Other financing activities amounted to $424,000 in FY2018, which was down 84.66% from $2.8 million recorded in FY2016.
  • Intellia Therapeutics' 5-year Other financing activities high stood at $2.8 million for FY2016, and its period low was $424,000 during FY2018.
  • For the 2-year period, Intellia Therapeutics' Other financing activities averaged around $1.6 million, with its median value being $1.6 million (2016).
  • Data for Intellia Therapeutics' Other financing activities shows a peak YoY skyrocketed of 359.14% (in 2016) over the last 5 years.
  • Intellia Therapeutics' Other financing activities (Yearly) stood at $602,000 in 2015, then soared by 359.14% to $2.8 million in 2016, then reached $424,000 in 2018.